G6PD deficiency
MONDO:0005775An X-linked genetic condition caused by alterations in the gene G6PD that result in moderately to severely decreased activity levels of the enzyme glucose-6-phosphate dehydrogenase. Most individuals with G6PD deficiency are asymptomatic throughout their life. Individuals with G6PD variants that cause G6PD deficiency are at risk for severe neonatal jaundice. These individuals are also at risk for acute hemolytic anemia in response to certain medication exposures, chemical exposures, infections, or consumption of fava beans.
Also known as: G-6-PD variant enzyme deficiency Anaemia, G-6-PD variant enzyme deficiency Anemia, G6PD, G6PD deficiency, glucose-6-phosphate dehydrogenase deficiency, glucosephosphate dehydrogenase deficiency, inborn error of glucose-6-phosphate dehydrogenase activity, inborn glucose-6-phosphate dehydrogenase activity disorder
6 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New hope for malaria patients with G6PD deficiency?
Disease control Recruiting nowThis study looks at how safe and effective primaquine is for treating vivax malaria in people with intermediate or deficient G6PD enzyme levels. About 100 adults with confirmed malaria and G6PD deficiency will receive either a high daily dose or a weekly dose of primaquine. The g…
Phase: PHASE4 • Sponsor: Menzies School of Health Research • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a common liver pill speed up jaundice recovery in newborns?
Symptom relief Recruiting nowThis study tests whether adding a medicine called ursodeoxycholic acid (UDCA) to standard light therapy helps clear jaundice faster in newborns. About 70 babies born at 34 weeks or later with jaundice will be randomly assigned to receive either light therapy alone or light therap…
Phase: NA • Sponsor: Tishreen University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC